Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B.P. Guiard
A New Class of Antidepressant Drugs in the Treatment of Psychiatric Disorders: The Triple Reuptake Inhibitors
Related publications
Antidepressant-Like Effects of LPM580153, a Novel Potent Triple Reuptake Inhibitor
Scientific Reports
Multidisciplinary
Kinase Inhibitors: A New Class of Antirheumatic Drugs
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Selective Serotonin Reuptake Inhibitors: A New Modality for the Treatment of Lymphoma/Leukaemia?
BMC Pharmacology
Serotonin Reuptake Inhibitors for Dizziness With Psychiatric Symptoms
Archives of Otolaryngology–Head & Neck Surgery
Selective-Serotonin Reuptake Inhibitors for the Treatment of Hypersensitive Esophagus
Therapeutic Advances in Gastroenterology
Gastroenterology
Triple Reuptake Inhibitors (TRIs): Do They Promise Us a Rose Garden?
Psychiatry and Clinical Psychopharmacology
Psychiatry
Mental Health
Pharmacology
Virtual Reality in the Treatment of Psychiatric Disorders
CNS Spectrums
Psychiatry
Mental Health
Neurology
From Pathophysiology to Novel Antidepressant Drugs: Glial Contributions to the Pathology and Treatment of Mood Disorders
Biological Psychiatry
Biological Psychiatry
Triple-Helical Transition State Analogues: A New Class of Selective Matrix Metalloproteinase Inhibitors
Journal of the American Chemical Society
Biochemistry
Colloid
Catalysis
Chemistry
Surface Chemistry